Alphanco receives conditional OK for Marvel acquisition
2021-03-18 16:43 ET - News Release Ms. Joanne Yan reports ALPHANCO VENTURE CORP. ANNOUNCES CONDITIONAL APPROVAL FOR ITS ACQUISITION OF MARVEL BIOTECHNOLOGY INC. Alphanco Venture Corp. has received conditional approval from the TSX Venture Exchange for its acquisition of all of the outstanding shares of Marvel Biotechnology Inc. as its proposed qualifying transaction as defined under TSX-V...
Alphanco to acquire Calgary biotech company as QT
2020-11-03 10:57 ET - News Release Mr. Roderick Matheson reports ALPHANCO VENTURE CORP. TO ACQUIRE MARVEL BIOTECHNOLOGY INC. IN A REVERSE TAKEOVER TRANSACTION Alphanco Venture Corp. has signed a merger agreement dated Oct. 28, 2020, pursuant to which the company will acquire all of the outstanding shares of Marvel Biotechnology Inc. The proposed transaction is intended to be a qualifying...